Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Novo Nordisk Pharmatech plans to build a $220.83m facility in Denmark for chronic disease medicine production, set to operate in 2027.

flag Novo Nordisk Pharmatech plans to construct a $220.83m facility in Denmark to meet increased demand for chronic disease medicines. flag The 1.5bn Danish crowns plant, set to be operational in 2027, will produce raw materials for Novo Nordisk's drugs and create about 50 new jobs. flag The company, home to popular treatments like Wegovy and Ozempic, has risen to become Europe's most valuable firm by market capitalization.

5 Articles